Mode VC
Christopher de Souza

Christopher de Souza

Director, Biopharma Team atBroadview VenturesMassachusetts
Broadview Ventures websiteFirm profile

Christopher de Souza is a Director at Broadview Ventures with over 40 years in cardiovascular and metabolic research and biopharma. He previously held roles at Novartis and SkyePharma US Inc.

What Christopher can write

Writes checks ofNot reported
Comes in atSeed, Series ACan lead the round
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Career

  1. Novartis · senior scientist
  2. Novartis · Director of Strategic Alliances
  3. SkyePharma US Inc. · Vice President of Business Development
  4. Broadview Ventures · Director
    Now
  5. Novartis · Senior Scientist in the Metabolic and Cardiovascular Diseases group; Director of Strategic Alliances
  6. Broadview Ventures · Director, Biopharma Team
    Now

Investments named in public bios

AcesionAllosterosCellAegisDecImmuneGila TherapeuticsHerantisMellitus PulmokineNuPulseProvasculonVentrinova

Focus

cardiovascularmetabolicbiopharmaceutical r&dcorporate strategybusiness developmentbiopharmaceutical

Education

University of Bombay, Masters in zoologyLouisiana State University, PhD in physiologyRutgers University, MBA

Also at Broadview Ventures

Daniel Gottlieb
Daniel GottliebManaging Director
Thomas Needham
Thomas NeedhamManaging Director
Benjamin Kreitman
Benjamin KreitmanPrincipal, Biopharma Team
David Prim
David PrimPrincipal, MedTech Team
Hewmun Lau
Hewmun LauPrincipal, Biopharma Team
Kelly Krajnik
Kelly KrajnikDirector, Head of MedTech

Partners like Christopher

At firms with a similar stage, sector and check size.

Ann DeWitt
Ann DeWittGeneral Partner, The Engine
Campbell MurrayCo-Founder & Managing Partner, Double Point Ventures
Stephen Knight
Stephen KnightSenior Managing Partner, F-Prime Capital
Alexander Harstrick
Alexander HarstrickManaging Partner, Co-Founder, J2 Ventures
Eric Bednarski
Eric BednarskiManaging Partner, MVM Life Science Partners
Anna FrenchManaging Partner, Qiming Venture Partners USA

Alert me when Broadview Ventures is active

One email when Christopher's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Christopher de Souza?

Christopher de Souza is a Director at Broadview Ventures with over 40 years in cardiovascular and metabolic research and biopharma. He previously held roles at Novartis and SkyePharma US Inc.

How much does Christopher de Souza invest?

Broadview Ventures has not reported a check size. It invests at seed, series a.

How do I pitch Christopher de Souza?

A warm intro from a founder Broadview Ventures backed works best.

What did Christopher de Souza do before Broadview Ventures?

senior scientist at Novartis; Director of Strategic Alliances at Novartis; Vice President of Business Development at SkyePharma US Inc.; Senior Scientist in the Metabolic and Cardiovascular Diseases group; Director of Strategic Alliances at Novartis.

Last updated 2026-10-15. Is this you? Ask for a correction.